L-dopa and selegiline for tyrosine hydroxylase deficiency

J Pediatr. 2001 Mar;138(3):451-2. doi: 10.1067/mpd.2001.110776.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Child
  • Female
  • Humans
  • Levodopa / therapeutic use*
  • Selegiline / therapeutic use*
  • Tyrosine 3-Monooxygenase / deficiency*

Substances

  • Antiparkinson Agents
  • Selegiline
  • Levodopa
  • Tyrosine 3-Monooxygenase